封面
市场调查报告书
商品编码
1611537

Fill Finish 药品契约製造市场规模、份额、趋势分析报告:按产品、按分子、按最终用途、按地区、细分市场预测,2025-2030 年

Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

Fill Finish 药品契约製造市场的成长和趋势

根据 Grand View Research, Inc. 的最新报告,预计 2025 年至 2030 年全球灌装药品契约製造市场将以 8.3% 的复合年增长率成长,到 2030 年将达到 290.6 亿美元。

对注射药物的需求不断增长是 Fillfinish 药品契约製造市场的关键驱动因素之一。注射药物是使用针头和注射器或其他输送系统直接输送到血液、肌肉组织或身体其他部位的药物。这些药物用于治疗多种疾病,包括癌症、自体免疫疾病和感染疾病。

近年来,由于多种因素,注射药物的需求稳定成长。关键驱动因素之一是癌症和糖尿病等需要长期注射药物治疗的慢性疾病的盛行率不断上升。此外,通常透过注射给药的新生技药品的开发也有助于增加对注射药物的需求。

COVID-19大流行对市场产生了重大影响。灌装加工契约製造是製药业的重要业务,将药品填充到管瓶、注射器、药筒和其他输送系统中。疫情扰乱了全球供应链,导致原材料和营运所需的其他关键零件短缺。这导致药物和疫苗的生产延迟,特别是用于治疗 COVID-19 患者的药物和疫苗。

此外,疫情也导致某些药品和疫苗的需求增加,进一步导致成品契约製造製造商的产能紧张。由于社交距离准则和为遏制病毒传播而实施的其他限制,许多製造商被迫减少产能。

Fill Finish 药品契约製造市场报告亮点

  • 由于解决未满足的医疗需求的可能性越来越大,大分子将在 2024 年占据最大的销售份额,达到 67.3%。
  • 由于管瓶灌装设备技术不断进步,2024年管瓶产业将占据最高的销售份额,达到53.4%。
  • 生物製药公司细分市场在2024年的收益占有率最高,为55.3%,药物和疫苗的持续开发是市场成长的主要驱动力。
  • 按地区划分,北美的灌装医药契约製造市场在全球市场占据主导地位,2024年销售份额为34.9%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 Fill Finish 药品契约製造市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第 4 章 Fill Finish 药品契约製造市场:产品业务分析

  • 2024年及2030年产品市场占有率
  • 产品细分仪表板
  • 2018-2030 年按产品分類的市场规模、预测与趋势分析
  • 预填充式注射器
  • 管瓶
  • 墨水匣
  • 其他的

第五章 Fill Finish 药品契约製造市场:分子业务分析

  • 2024年及2030年分子市场占有率
  • 分子细分仪表板
  • 2018-2030 年按分子分類的市场规模、预测与趋势分析
  • 高分子
  • 小分子

第六章 Fill Finish 药品契约製造市场:最终用途业务分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
  • 生物製药公司
  • 製药公司

第 7 章 Fill Finish 药品契约製造市场:按产品、分子和最终用途按地区进行估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分,2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分,2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区划分,2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分,2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分,2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Boehringer Ingelheim International GmbH
    • Catalent, Inc(acquired by Novo Holdings A/S)
    • Societal CDMO(Recro Pharma, Inc)
    • Baxter
    • Eurofins Scientific
    • Symbiosis Pharmaceutical Services Ltd
    • MabPlex International Co. Ltd.
    • Recipharm AB
    • Fresenius Kabi, USA LLC
    • Lonza
Product Code: GVR-4-68039-949-4

Fill-Finish Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global fill-finish pharmaceutical contract manufacturing market size is estimated to reach USD 29.06 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for injectable drugs is one of the primary drivers of the fill-finish pharmaceutical contract manufacturing market. Injectable drugs are medications that are delivered directly into the bloodstream, muscle tissue, or other parts of the body using a needle and syringe or other delivery system. These drugs are used to treat a wide range of conditions, including cancer, autoimmune disorders, and infectious diseases, among others.

The demand for injectable drugs has been growing steadily in recent years due to several factors. One of the key drivers is the increasing prevalence of chronic diseases such as cancer and diabetes, which require long-term treatment with injectable medications. Additionally, the development of new biologic drugs, which are often administered via injection, has also contributed to the growing demand for injectable drugs.

The COVID-19 pandemic has had a significant impact on the market. Fill-finish contract manufacturing is an essential part of the pharmaceutical industry, which involves the filling and finishing of drug products into vials, syringes, cartridges, and other delivery systems. The pandemic caused disruptions in the global supply chain, resulting in shortages of raw materials and other critical components required for operations. This has led to delays in the production of drugs and vaccines, particularly those used in the treatment of COVID-19 patients.

Moreover, the pandemic has also caused an increase in demand for certain drugs and vaccines, further straining the capacity of fill-finish contract manufacturers. Many manufacturers have been forced to operate at reduced capacity due to social distancing guidelines and other restrictions imposed to control the spread of the virus.

Fill-Finish pharmaceutical Contract Manufacturing Market Report Highlights:

  • The large molecules segment accounted for the largest revenue share of 67.3% in 2024 due to the rising potential to treat unmet medical needs.
  • The vials segment is accounted for the highest revenue share of 53.4% in 2024 due to increasing technological advancements in vial filling equipment.
  • The biopharmaceutical companies segment accounted for the highest revenue share of 55.3% in 2024, an increase in the development of drugs and vaccines is the key factor for the growth of the market.
  • By region, North America fill-finish pharmaceutical contract manufacturing market dominated the global market with a revenue share of 34.9% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Molecule
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fill-finish Pharmaceutical Contract Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fill-finish Pharmaceutical Contract Manufacturing Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Prefilled Syringes
    • 4.4.1. Prefilled Syringes Market, 2018 - 2030 (USD Million)
  • 4.5. Vials
    • 4.5.1. Vials Market, 2018 - 2030 (USD Million)
  • 4.6. Cartridges
    • 4.6.1. Cartridges Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Fill-finish Pharmaceutical Contract Manufacturing Market: Molecule Business Analysis

  • 5.1. Molecule Market Share, 2024 & 2030
  • 5.2. Molecule Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
  • 5.4. Large Molecules
    • 5.4.1. Large Molecules Market, 2018 - 2030 (USD Million)
  • 5.5. Small Molecules
    • 5.5.1. Small Molecules Market, 2018 - 2030 (USD Million)

Chapter 6. Fill-finish Pharmaceutical Contract Manufacturing Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical Companies
    • 6.5.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Fill-finish Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis by Product, Molecule, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Sartorius AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Boehringer Ingelheim International GmbH
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Catalent, Inc (acquired by Novo Holdings A/S)
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Societal CDMO (Recro Pharma, Inc)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Baxter
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Eurofins Scientific
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Symbiosis Pharmaceutical Services Ltd
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. MabPlex International Co. Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Recipharm AB
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Fresenius Kabi, USA LLC
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Lonza
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global fill-finish pharmaceutical contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 6 Global fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 10 North America fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 16 Canada fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 19 Mexico fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 23 Europe fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 26 UK Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 29 Germany fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 31 France fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 32 France Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 35 Italy fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 38 Spain fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 41 Norway Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 44 Denmark fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 47 Sweden fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 54 Japan fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 56 China fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 57 China fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 59 India fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 60 India fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 63 Australia fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 65 South Korea fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 66 South Korea fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 69 Thailand fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 73 Latin America fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 76 Brazil fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 79 Argentina fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 86 South Africa fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 92 UAE fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 95 Kuwait fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fill-finish pharmaceutical contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and molecule outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Fill-finish pharmaceutical contract manufacturing market dynamics
  • Fig. 13 Fill-finish pharmaceutical contract manufacturing market: Porter's five forces analysis
  • Fig. 14 Fill-finish pharmaceutical contract manufacturing market: PESTLE analysis
  • Fig. 15 Fill-finish pharmaceutical contract manufacturing market: Product segment dashboard
  • Fig. 16 Fill-finish pharmaceutical contract manufacturing market: Product market share analysis, 2024 & 2030
  • Fig. 17 Prefilled syringes market, 2018 - 2030 (USD Million)
  • Fig. 18 Vials market, 2018 - 2030 (USD Million)
  • Fig. 19 Cartridges market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Fill-finish pharmaceutical contract manufacturing market: Molecule segment dashboard
  • Fig. 22 Fill-finish pharmaceutical contract manufacturing market: Molecule market share analysis, 2024 & 2030
  • Fig. 23 Large molecules market, 2018 - 2030 (USD Million)
  • Fig. 24 Small molecules market, 2018 - 2030 (USD Million)
  • Fig. 25 Fill-finish pharmaceutical contract manufacturing market: End use segment dashboard
  • Fig. 26 Fill-finish pharmaceutical contract manufacturing market: End use market share analysis, 2024 & 2030
  • Fig. 27 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Fill-finish pharmaceutical contract manufacturing market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 France country dynamics
  • Fig. 45 France fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 China country dynamics
  • Fig. 60 China fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 India country dynamics
  • Fig. 62 India fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 74 MEA fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework